December 24, 2009 – The U.S. Department of Justice and Boston Scientific Corp. yesterday entered into a civil settlement regarding an investigation of post-market surveys conducted by Guidant Corp., before Boston Scientific acquired the company in 2006.

December 24, 2009 – A clinical reference and pharmaceutical database application was released this week for the Google Android personal digital assistant (PDA) device.

December 23, 2009 – The American College of Cardiology’s (ACC) ACC.10 and i2 Summit 2010 is March 14-16, 2010, in Atlanta.

December 23, 2009 – An investigational beta-blocker drug may be tested to see if it helps slow the progression of chronic heart failure in patients who have a specific genotype.

December 23, 2009 – The Cleveland Clinic this week initiated a phase II trial examining a new oral therapy for the treatment of atherosclerosis in patients with stable coronary artery disease (CAD).

December 22, 2009 – A new study is the first to specifically identify the year immediately around a woman’s final menstrual period as the time of most adverse changes in the lipid profile in women. The study appears in the Dec. 15-22, 2009, print double issue of the Journal of the American College of Cardiology (JACC) and the Prevention and Outcomes Quarterly Focus Issue.

December 22, 2009 – A drug manufacturer recently filed paperwork with the FDA to produce a generic version of the cholesterol-lowering medication Vytorin.

December 21, 2009 – Revised guidelines on the use of beta-blockers for noncardiac surgery say therapy should neither be initiated on the day of surgery, nor stopped abruptly peri- or postoperatively.

December 21, 2009 – The recently introduced GORE PROPATEN Vascular Graft has integrated rings that reduce the cross-sectional profile by 24 percent as compared to externally ringed grafts, and its radial reinforcement allows for improved blood flow.

December 18, 2009 – Results from the Europella registry, evaluating the safety and feasibility of the Abiomed Impella 2.5 circulatory assist device in high-risk percutaneous coronary intervention (PCI) procedures, was published in the Dec. 15 issue of the Journal of the American College of Cardiology (JACC).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now